Dental News - Advancing edentulous solutions

Search Dental Tribune

Advancing edentulous solutions

Hans Geiselhöringer is the President of Nobel Biocare and Dental Imaging (Photograph: Claudia Duschek, DTI)
Hans Geiselhöringer, President Nobel Biocare and Dental Imaging

Hans Geiselhöringer, President Nobel Biocare and Dental Imaging

Sat. 25 June 2016


Since the very beginning, Nobel Biocare has focused on edentulous solutions, helping those who need it most. For over half a century now, this dedication to treating edentulism has remained unwavering, even in the face of skepticism, criticism and copycat products. There was a time when people doubted the efficacy of the All-on-4 treatment concept. Now, 12 years and hundreds of thousands of patients later, we can be proud that we stayed the course.

Because we kept the faith and trusted the feedback from patients, input from clinicians who shared our goal and, above all, the science, we have made substantial progress toward ending edentulism that would otherwise have been lost. There are now 48 peer-reviewed studies on the All-on-4 treatment concept—all using Nobel Biocare components.

Today, those who were our most vocal detractors are now trying to catch up, but we have a signifi cant head start and are already advancing. The next generation of the All-on-4 treatment concept and products is already here. With new implant variants and restorative components, we are further improving workfl ow effi ciency gains and ease of use to shorten prosthetic protocols and procedures significantly.

In addition, our forthcoming Trefoil edentulous concept will allow even more patients to benefit from a fixed implant restoration. Developed with some of the world’s leading clinicians, it is a truly innovative full-arch restoration on three implants with a revolutionary prosthetic framework. Feedback from early testers has been excellent, and we are excited to be bringing this new, affordable option to the market soon.

With an estimated 3.6 billion people with missing teeth worldwide, edentulism is a global issue; some would even say an epidemic. The aforementioned solutions can help. The treatment of edentulous and soon-to-be edentulous patients is where the potential improvement in quality of life is greatest, and so Nobel Biocare’s focus in this area will remain great as well.

To post a reply please login or register